Evolution of the Average Target: Achieve Life Sciences, Inc.

Evolution of the Target Price: Achieve Life Sciences, Inc.

Changes in Analyst Recommendations: Achieve Life Sciences, Inc.

2ba4.A_jEk1Dv4YahUtc4aYpgJFQqNaOjIy5NKxgHTPkAdjo.N7aep2CVlrT1AeJWP8saEy5HB8ziVFp8Zkx_GYpXBGI7gK3MHL3XtdU8ng~719b17e772b101e1f3e32251f58527bc

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+137.52%
+35.33%
+21.72%
+25.07%
+55.91%
+46.2%
-5.24%
+10.62%
+39.43%
Average +40.73%
Weighted average by Cap. +32.16%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
5.520USD
Average target price
13.11USD
Spread / Average Target
+137.52%
High Price Target
21.00USD
Spread / Highest target
+280.43%
Low Price Target
9.000USD
Spread / Lowest Target
+63.04%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Canaccord Genuity
Raymond James
Oppenheimer
JonesTrading Institutional Services
Lake Street
Maxim
Alliance Global Partners
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
5.520USD
Average target price
13.11USD
Spread / Average Target
+137.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACHV Stock
  4. Consensus Achieve Life Sciences, Inc.
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!